Acadia Stock Jumps on Positive Dementia-Related Psychosis Drug Data – Xconomy

Acadia Stock Jumps on Positive Dementia-Related Psychosis Drug Data – Xconomy
Acadia Stock Jumps on Positive Dementia-Related Psychosis Drug Data  XconomyAn Acadia Pharmaceuticals drug that's already approved for psychosis associated with Parkinson's disease could soon be heading to an FDA review to expand. ... read more
Source: Google NewsPublished on 2019-09-09